Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005378834 | SCV006040632 | uncertain significance | Inborn genetic diseases | 2025-01-19 | criteria provided, single submitter | clinical testing | The c.2734A>T (p.I912F) alteration is located in exon 21 (coding exon 21) of the NBEA gene. This alteration results from a A to T substitution at nucleotide position 2734, causing the isoleucine (I) at amino acid position 912 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |